Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02903069
Recruitment Status : Completed
First Posted : September 16, 2016
Last Update Posted : April 19, 2021
Sponsor:
Collaborator:
Triphase
Information provided by (Responsible Party):
Celgene

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 25, 2021
Actual Study Completion Date : January 25, 2021